Follow-up of inflammation and lung function in patients with diisocyanates induced asthma

P. L. Piirilä, A. Meuronen, M. L. Majuri, H. Wolff, H. Alenius, A. Laitinen (Helsinki, Finland)

Source: Annual Congress 2005 - Occupational airway disease: allergy and irritation
Session: Occupational airway disease: allergy and irritation
Session type: Thematic Poster Session
Number: 3849
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. L. Piirilä, A. Meuronen, M. L. Majuri, H. Wolff, H. Alenius, A. Laitinen (Helsinki, Finland). Follow-up of inflammation and lung function in patients with diisocyanates induced asthma. Eur Respir J 2005; 26: Suppl. 49, 3849

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Follow-up of patients with severe asthma by noninvasive parameters of airway inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 52s
Year: 2001

Atopy, lung function and bronchial responsiveness in former paediatric asthma patients
Source: Eur Respir J 2005; 26: Suppl. 49, 450s
Year: 2005

Monitoring asthma in children: lung function, bronchial hyperresponsiveness and inflammation
Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force
Year: 2014



Respiratory symptoms, airway inflammation and lung function in workers at risk of occupational asthma
Source: International Congress 2019 – Airway and parenchymal diseases in occupational and environmental lung diseases
Year: 2019


Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation
Source: Eur Respir Rev 2015; 24: 204-215
Year: 2015



The influence of obesity on bronchial hyperresponsiveness, airway and systemic inflammation, lung function and quality of life in patients with asthma
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008

Sputum induction elicits different peripheral airways responses in healthy subjects, asthma and allergic rhinitis patients
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015

Systemic and airway inflammation and the presence of emphysema in patients with COPD
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009


Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001

Role of neutrophils in airway inflammation in patients with pneumoconiosis and COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 322s
Year: 2004

Airways and systemic inflammation and correlation to lung function in smokers and in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 651s
Year: 2006

Baseline airway inflammation may be a determinant of ozone response in asthmatic patients
Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease
Year: 2012

The effects of capsaicin on airway inflammation in asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 586s
Year: 2004

The abnormalities in spontaneous and Fas-induced apoptosis in atopic bronchial asthma (ABA): the key to chronic lung inflammation
Source: Eur Respir J 2006; 28: Suppl. 50, 228s
Year: 2006

Is lung emphysema in COPD patients reflected by central airways inflammation?
Source: Eur Respir J 2003; 22: Suppl. 45, 207s
Year: 2003

Mild improvement in symptoms and pulmonary function in a long-term follow-up of patients with TDI-induced asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 604s
Year: 2005

The impact of obesity on airway and lung parenchyma remodelling in a murine model of chronic allergic asthma
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008

Airways' remodelling contributes to abnormal lung function and bronchial hyperresponsiveness during clinical remission of atopic asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 4s
Year: 2001

Changes in lung functions and inflammatory markers in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens
Source: Eur Respir J 2005; 26: Suppl. 49, 734s
Year: 2005

Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline
Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges
Year: 2009